Feng Peng

1.1k total citations
33 papers, 767 citations indexed

About

Feng Peng is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Feng Peng has authored 33 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 11 papers in Molecular Biology. Recurrent topics in Feng Peng's work include Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis C virus research (6 papers). Feng Peng is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis C virus research (6 papers). Feng Peng collaborates with scholars based in China, United States and India. Feng Peng's co-authors include Yu Jiang, Yongfang Jiang, Xinqiang Xiao, Guozhong Gong, Yi Tian, You Lü, Yuquan Wei, Meijuan Huang, Bo He and Wei Li and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Feng Peng

32 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Peng China 15 273 225 208 146 136 33 767
Wen-Hui Su Taiwan 14 471 1.7× 270 1.2× 315 1.5× 99 0.7× 68 0.5× 23 919
Yuling Chen Taiwan 17 260 1.0× 191 0.8× 119 0.6× 74 0.5× 75 0.6× 32 701
Carolina Armengol Spain 18 486 1.8× 172 0.8× 140 0.7× 211 1.4× 74 0.5× 32 940
Haohai Zhang China 17 372 1.4× 201 0.9× 291 1.4× 61 0.4× 67 0.5× 27 784
Teruyuki Ueda Japan 10 350 1.3× 182 0.8× 286 1.4× 226 1.5× 79 0.6× 21 830
Benjamin Ruf United States 14 280 1.0× 343 1.5× 146 0.7× 192 1.3× 53 0.4× 29 869
Xi‐Dai Long China 22 793 2.9× 190 0.8× 480 2.3× 144 1.0× 102 0.8× 65 1.2k
Biao Nie China 11 243 0.9× 244 1.1× 185 0.9× 308 2.1× 49 0.4× 20 785
Sabine Strommer Austria 18 432 1.6× 213 0.9× 123 0.6× 80 0.5× 86 0.6× 25 769

Countries citing papers authored by Feng Peng

Since Specialization
Citations

This map shows the geographic impact of Feng Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Peng more than expected).

Fields of papers citing papers by Feng Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Peng. The network helps show where Feng Peng may publish in the future.

Co-authorship network of co-authors of Feng Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Peng. A scholar is included among the top collaborators of Feng Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Peng. Feng Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Xiaolong, et al.. (2025). Microdefect Detection and Characterization Using Pot-Core Coils and LDC. IEEE Sensors Journal. 25(8). 13894–13903. 1 indexed citations
2.
Deng, Xiaofeng, Zongjuan Li, Zhenyu Xu, & Feng Peng. (2025). CAT1 modulates hepatic fibrosis via IL-6-mediated inflammatory and fibrogenic pathways in hepatic stellate cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1873(1). 120075–120075.
3.
4.
Yuan, Qiang, Yingying Chen, Xiaoyu Li, et al.. (2023). Corynoline inhibits esophageal squamous cell carcinoma growth via targeting Pim-3. Phytomedicine. 123. 155235–155235. 5 indexed citations
5.
Peng, Feng, Yi Tian, Jing Ma, et al.. (2020). CAT1 silencing inhibits TGF-β1-induced mouse hepatic stellate cell activation in vitro and hepatic fibrosis in vivo. Cytokine. 136. 155288–155288. 4 indexed citations
6.
Lei, Jianhua, Feng Peng, Zi Chen, & Xinqiang Xiao. (2019). Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?. BMC Infectious Diseases. 19(1). 363–363. 5 indexed citations
7.
Liu, Tong, Feng Peng, Jing Yu, et al.. (2019). LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression. Analytical and Bioanalytical Chemistry. 411(20). 5079–5088. 43 indexed citations
8.
Peng, Feng, Yingzi Liu, Chenjie He, et al.. (2018). Prediction of platinum-based chemotherapy efficacy in lung cancer based on LC–MS metabolomics approach. Journal of Pharmaceutical and Biomedical Analysis. 154. 95–101. 18 indexed citations
9.
10.
Tian, Yi, Xinqiang Xiao, Xing Gong, et al.. (2017). HBx promotes cell proliferation by disturbing the cross-talk between miR-181a and PTEN. Scientific Reports. 7(1). 40089–40089. 28 indexed citations
11.
Lei, Jianhua, Xu Yang, Xinqiang Xiao, Zi Chen, & Feng Peng. (2017). A preliminary investigation on single nucleotide polymorphism rs2287622 of bile salt export pump gene in patients with chronic hepatitis C virus infection in Hunan, China. BMC Gastroenterology. 17(1). 42–42. 1 indexed citations
12.
Zhang, Min, Yongfang Jiang, Xinqiang Xiao, et al.. (2017). Differences in IP-10, TLR4 and IRF5/3 between SVR and non-SVR HCV-1 patients treated with PEG-IFN and ribavirin. Molecular Medicine Reports. 15(4). 2318–2324. 4 indexed citations
13.
Lei, Jianhua, Xing Gong, Xinqiang Xiao, Zi Chen, & Feng Peng. (2017). Genotype distribution of hepatitis C virus in 952 cases from 2014 to 2016 in Hunan Province, China. Archives of Medical Science. 14(5). 1055–1060. 1 indexed citations
14.
Xiao, Xinqiang, et al.. (2016). Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication. Virus Genes. 52(1). 22–28. 14 indexed citations
15.
Liu, Xinyu, Feng Peng, Yajie Pan, & Jun Chen. (2015). Advanced therapeutic strategies for HBV-related acute-on-chronic liver failure. Hepatobiliary & pancreatic diseases international. 14(4). 354–360. 9 indexed citations
16.
Niu, Xiaoyu, Megan Delisle, Feng Peng, et al.. (2013). Brain Metastases in Women With Epithelial Ovarian Cancer: Multimodal Treatment Including Surgery or Gamma-Knife Radiation Is Associated With Prolonged Survival. Journal of Obstetrics and Gynaecology Canada. 35(9). 816–822. 18 indexed citations
17.
Peng, Milin, Yi Li, Min Zhang, et al.. (2013). Clinical features in different age groups of patients with autoimmune hepatitis. Experimental and Therapeutic Medicine. 7(1). 145–148. 17 indexed citations
18.
Huang, Meijuan, Yu Jiang, Weiping Liu, et al.. (2007). Early or Up-Front Radiotherapy Improved Survival of Localized Extranodal NK/T-Cell Lymphoma, Nasal-Type in the Upper Aerodigestive Tract. International Journal of Radiation Oncology*Biology*Physics. 70(1). 166–174. 114 indexed citations
19.
Zhang, Rundong, Lin Tian, Fei Xiao, et al.. (2006). Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma. Gene Therapy. 13(17). 1263–1271. 54 indexed citations
20.
Peng, Feng, Yuquan Wei, Li Tian, et al.. (2002). Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. Journal of Cancer Research and Clinical Oncology. 128(4). 223–230. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen-Hui Su Breakdown of academic impact, for papers by Yuling Chen Breakdown of academic impact, for papers by Carolina Armengol Breakdown of academic impact, for papers by Haohai Zhang Breakdown of academic impact, for papers by Teruyuki Ueda Breakdown of academic impact, for papers by Benjamin Ruf Breakdown of academic impact, for papers by Xi‐Dai Long Breakdown of academic impact, for papers by Biao Nie Breakdown of academic impact, for papers by Sabine Strommer
Rankless by CCL
2026